RCMT
RCMFNasdaq / Commercial & Professional Services
Last Price
At close
2026-06-02
Current thesis
RCM still shows resilient profitability and a healthier mix in Specialty Healthcare, with the Q1 print demonstrating earnings durability despite Engineering weakness. The packet’s $31 median analyst target implies roughly 40% upside from the $22.18 anchor if execution and controls stabilize.
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.0.
What can break
Auditor transition from EisnerAmper to Withum increases governance scrutiny until remediation is demonstrated.
Momentum
8
Value
58
Sentiment
53
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $24.00 · Bull $31.00 · Bear $18.00
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-20 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $31.00
Why
Momentum8 · Δ7d -50.5
Value58 · Δ7d +0.0
Sentiment53 · Δ7d +0.7
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Value · See fundamentals
Momentum
8
34% active weight
Current posture
7d trendSoftening
Δ7d
-50.5
Δ21d
-90.5
Value
58
32% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
+4.9
Sentiment
53
33% active weight
Current posture
7d trendFlat
Δ7d
+0.7
Δ21d
+18.0
Why this grade
Composite grade F. Momentum 7.6 / Value 58.2 / Sentiment 53.2
Fundamentals (TTM)As of 2026-06-01
Fundamentals (TTM)
As of 2026-06-01
Market Cap
$159.47M
Beta
-0.03
Shares Out
7.41M
P/E (TTM)
11.7
P/S (TTM)
0.48
P/FCF (TTM)
42.41
Rev YoY
+16.4%
EPS YoY
-15.8%
Gross Margin
+27.5%
Op Margin
+7.0%
Net Debt
$32.05M
Current Ratio
1.98
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology